CN103432310A - 一种治疗灼热型腋下急性化脓性淋巴结炎的中药制备方法 - Google Patents
一种治疗灼热型腋下急性化脓性淋巴结炎的中药制备方法 Download PDFInfo
- Publication number
- CN103432310A CN103432310A CN2013103675023A CN201310367502A CN103432310A CN 103432310 A CN103432310 A CN 103432310A CN 2013103675023 A CN2013103675023 A CN 2013103675023A CN 201310367502 A CN201310367502 A CN 201310367502A CN 103432310 A CN103432310 A CN 103432310A
- Authority
- CN
- China
- Prior art keywords
- grams
- herba
- radix
- root
- heat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 31
- 230000001154 acute effect Effects 0.000 title claims abstract description 22
- 238000000034 method Methods 0.000 title abstract description 7
- 210000001099 axilla Anatomy 0.000 title abstract description 6
- 201000009052 suppurative lymphadenitis Diseases 0.000 title abstract 4
- 238000011282 treatment Methods 0.000 claims abstract description 22
- 239000007788 liquid Substances 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 201000003265 lymphadenitis Diseases 0.000 claims description 18
- 241000628997 Flos Species 0.000 claims description 12
- 239000000796 flavoring agent Substances 0.000 claims description 7
- 235000019634 flavors Nutrition 0.000 claims description 7
- 241001094455 Cipangopaludina chinensis Species 0.000 claims description 6
- 241000756943 Codonopsis Species 0.000 claims description 6
- 239000009806 pulsatillae Substances 0.000 claims description 6
- 229940126678 chinese medicines Drugs 0.000 claims description 3
- 239000003643 water by type Substances 0.000 claims description 3
- 229940079593 drug Drugs 0.000 abstract description 12
- 230000000694 effects Effects 0.000 abstract description 10
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 230000008901 benefit Effects 0.000 abstract description 3
- 241001093951 Ailanthus altissima Species 0.000 abstract 1
- 241000205585 Aquilegia canadensis Species 0.000 abstract 1
- 241000722824 Ardisia crenata Species 0.000 abstract 1
- 241000218176 Corydalis Species 0.000 abstract 1
- 244000110343 Elephantopus scaber Species 0.000 abstract 1
- 241000490229 Eucephalus Species 0.000 abstract 1
- 241000221079 Euphorbia <genus> Species 0.000 abstract 1
- 244000130270 Fagopyrum tataricum Species 0.000 abstract 1
- 235000014693 Fagopyrum tataricum Nutrition 0.000 abstract 1
- 241000237858 Gastropoda Species 0.000 abstract 1
- 244000303040 Glycyrrhiza glabra Species 0.000 abstract 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 abstract 1
- 241000466334 Hemsleya macrosperma Species 0.000 abstract 1
- 244000130592 Hibiscus syriacus Species 0.000 abstract 1
- 235000018081 Hibiscus syriacus Nutrition 0.000 abstract 1
- 241000209035 Ilex Species 0.000 abstract 1
- 235000003332 Ilex aquifolium Nutrition 0.000 abstract 1
- 235000003365 Ilex pubescens Nutrition 0.000 abstract 1
- 241001100932 Ilex pubescens Species 0.000 abstract 1
- 235000002296 Ilex sandwicensis Nutrition 0.000 abstract 1
- 235000002294 Ilex volkensiana Nutrition 0.000 abstract 1
- 240000006550 Lantana camara Species 0.000 abstract 1
- 241001633628 Lycoris Species 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 244000148137 Patrinia villosa Species 0.000 abstract 1
- 235000019109 Patrinia villosa Nutrition 0.000 abstract 1
- 244000215777 Plumeria rubra Species 0.000 abstract 1
- 235000013087 Plumeria rubra Nutrition 0.000 abstract 1
- 241000206469 Pulsatilla Species 0.000 abstract 1
- 244000081923 Rumex patientia Species 0.000 abstract 1
- 235000008330 Rumex patientia Nutrition 0.000 abstract 1
- 241000612118 Samolus valerandi Species 0.000 abstract 1
- 241001647091 Saxifraga granulata Species 0.000 abstract 1
- 241000915604 Scutellaria barbata Species 0.000 abstract 1
- 240000003705 Senecio vulgaris Species 0.000 abstract 1
- 240000007267 Stephania hernandifolia Species 0.000 abstract 1
- 241001530121 Trollius Species 0.000 abstract 1
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 abstract 1
- 240000001519 Verbena officinalis Species 0.000 abstract 1
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 abstract 1
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 abstract 1
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 abstract 1
- 241000028204 Vincetoxicum atratum Species 0.000 abstract 1
- 230000003115 biocidal effect Effects 0.000 abstract 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 abstract 1
- 231100001231 less toxic Toxicity 0.000 abstract 1
- 235000011477 liquorice Nutrition 0.000 abstract 1
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 abstract 1
- 229940124530 sulfonamide Drugs 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 231100000614 poison Toxicity 0.000 description 45
- 239000003440 toxic substance Substances 0.000 description 41
- 210000004185 liver Anatomy 0.000 description 28
- 230000001737 promoting effect Effects 0.000 description 28
- 210000004072 lung Anatomy 0.000 description 23
- 239000008280 blood Substances 0.000 description 22
- 210000004369 blood Anatomy 0.000 description 22
- 208000004880 Polyuria Diseases 0.000 description 20
- 230000035619 diuresis Effects 0.000 description 20
- 210000002429 large intestine Anatomy 0.000 description 18
- 210000000952 spleen Anatomy 0.000 description 15
- 210000002784 stomach Anatomy 0.000 description 15
- 235000009508 confectionery Nutrition 0.000 description 14
- 210000002216 heart Anatomy 0.000 description 14
- 230000008961 swelling Effects 0.000 description 12
- 230000023597 hemostasis Effects 0.000 description 11
- 238000001816 cooling Methods 0.000 description 9
- 206010020751 Hypersensitivity Diseases 0.000 description 8
- 230000007815 allergy Effects 0.000 description 8
- 230000001939 inductive effect Effects 0.000 description 8
- 208000026935 allergic disease Diseases 0.000 description 7
- 206010030113 Oedema Diseases 0.000 description 5
- 229930182555 Penicillin Natural products 0.000 description 5
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 5
- 206010037660 Pyrexia Diseases 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 238000001035 drying Methods 0.000 description 5
- 230000004438 eyesight Effects 0.000 description 5
- 238000010255 intramuscular injection Methods 0.000 description 5
- 239000007927 intramuscular injection Substances 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 229940049954 penicillin Drugs 0.000 description 5
- 230000007096 poisonous effect Effects 0.000 description 5
- 231100000252 nontoxic Toxicity 0.000 description 4
- 230000003000 nontoxic effect Effects 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 241000721047 Danaus plexippus Species 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 208000003455 anaphylaxis Diseases 0.000 description 3
- 230000004087 circulation Effects 0.000 description 3
- 210000000232 gallbladder Anatomy 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 230000007803 itching Effects 0.000 description 3
- 239000010985 leather Substances 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- UUTKICFRNVKFRG-WDSKDSINSA-N (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSCN1C(=O)[C@H]1NC(=O)CC1 UUTKICFRNVKFRG-WDSKDSINSA-N 0.000 description 2
- 206010002199 Anaphylactic shock Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 102000003929 Transaminases Human genes 0.000 description 2
- 108090000340 Transaminases Proteins 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 210000001364 upper extremity Anatomy 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 201000010000 Agranulocytosis Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- 208000005584 Alcoholic Intoxication Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- WZPBZJONDBGPKJ-UHFFFAOYSA-N Antibiotic SQ 26917 Natural products O=C1N(S(O)(=O)=O)C(C)C1NC(=O)C(=NOC(C)(C)C(O)=O)C1=CSC(N)=N1 WZPBZJONDBGPKJ-UHFFFAOYSA-N 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 206010006326 Breath odour Diseases 0.000 description 1
- 206010009657 Clostridium difficile colitis Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011509 Crystalluria Diseases 0.000 description 1
- 206010011894 Deafness permanent Diseases 0.000 description 1
- 208000006313 Delayed Hypersensitivity Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013886 Dysaesthesia Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 206010018687 Granulocytopenia Diseases 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010033661 Pancytopenia Diseases 0.000 description 1
- 102100027378 Prothrombin Human genes 0.000 description 1
- 108010094028 Prothrombin Proteins 0.000 description 1
- 208000003100 Pseudomembranous Enterocolitis Diseases 0.000 description 1
- 206010037128 Pseudomembranous colitis Diseases 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- WZPBZJONDBGPKJ-VEHQQRBSSA-N aztreonam Chemical compound O=C1N(S([O-])(=O)=O)[C@@H](C)[C@@H]1NC(=O)C(=N/OC(C)(C)C(O)=O)\C1=CSC([NH3+])=N1 WZPBZJONDBGPKJ-VEHQQRBSSA-N 0.000 description 1
- 229960003644 aztreonam Drugs 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 229960003669 carbenicillin Drugs 0.000 description 1
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 1
- 229960004682 cefoperazone Drugs 0.000 description 1
- GCFBRXLSHGKWDP-XCGNWRKASA-N cefoperazone Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC(O)=CC=1)C(=O)N[C@@H]1C(=O)N2C(C(O)=O)=C(CSC=3N(N=NN=3)C)CS[C@@H]21 GCFBRXLSHGKWDP-XCGNWRKASA-N 0.000 description 1
- 229960004261 cefotaxime Drugs 0.000 description 1
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 210000000860 cochlear nerve Anatomy 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 239000002895 emetic Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 208000001297 phlebitis Diseases 0.000 description 1
- 229960002292 piperacillin Drugs 0.000 description 1
- IVBHGBMCVLDMKU-GXNBUGAJSA-N piperacillin Chemical compound O=C1C(=O)N(CC)CCN1C(=O)N[C@H](C=1C=CC=CC=1)C(=O)N[C@@H]1C(=O)N2[C@@H](C(O)=O)C(C)(C)S[C@@H]21 IVBHGBMCVLDMKU-GXNBUGAJSA-N 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- ZRHANBBTXQZFSP-UHFFFAOYSA-M potassium;4-amino-3,5,6-trichloropyridine-2-carboxylate Chemical compound [K+].NC1=C(Cl)C(Cl)=NC(C([O-])=O)=C1Cl ZRHANBBTXQZFSP-UHFFFAOYSA-M 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940039716 prothrombin Drugs 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229960005404 sulfamethoxazole Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- JLKIGFTWXXRPMT-UHFFFAOYSA-N sulphamethoxazole Chemical compound O1C(C)=CC(NS(=O)(=O)C=2C=CC(N)=CC=2)=N1 JLKIGFTWXXRPMT-UHFFFAOYSA-N 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 201000005060 thrombophlebitis Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
一种治疗灼热型腋下急性化脓性淋巴结炎的中药制备方法,属于中药制备方法技术领域。目前治疗灼热型腋下急性化脓性淋巴结炎一般采用抗菌素及磺胺类药物,其缺点是毒副作用大。该发明的技术方案为:取马鞭草、天荞麦根、无花果、木槿皮、五色梅、牛西西、毛冬青、凤眼草、石蒜、田螺、白薇、白头翁、白花蛇舌草、山白菊、山海螺、千里光、千金藤、小飞扬草、半枝莲、地丁、朱砂根、连翘、岗梅根、忍冬藤、鸡蛋花、苦地胆、虎耳草、败酱草、罗锅底、金莲花和甘草等,将以上中药放入水中浸泡,然后文火煎制,过滤去渣煎出的药液即为治疗灼热型腋下急性化脓性淋巴结炎的中药。它的优点是:制成的中药毒副作用小,疗程短,治愈率高。
Description
技术领域
本发明涉及中药制备方法技术领域,更具体的讲是一种治疗灼热型腋下急性化脓性淋巴结炎的中药制备方法。
背景技术
目前治疗灼热型腋下急性化脓性淋巴结炎,一般采用:
1、哌拉西林:肌注后偶有局部疼痛,快速静脉推注可导致暂时性恶心、胸闷、咳嗽、发热、口腔异味、眼结膜充血,变态反应(皮疹、痒感、头晕、麻木、发热等),用药前必须注意青霉素有无过敏史,并做青霉素皮试。
2、羧苄西林:可以出现各种类型的变态反应。大剂量给药后可能引起神经毒反应、肺水肿,用药期间可能出现短暂性转氨酶升高与粒细胞减少。
3、氨苄西林:大量口服常出现胃肠道不适。肌注局部有疼痛。无论口服或注射均可引起变态反应,以皮疹为多见。用药前必须先做皮试。
4、阿莫西林:偶见皮疹,口服大量后可有恶心、上腹部不适、腹泻等;伪膜性结肠炎。
5、头孢噻肟:肌注局部可有疼痛;静注时可有血栓性静脉炎发生;皮疹、药物热等变态反应。
6、青霉素:本品易发生变态反应,特别是过敏性休克(最危险的过敏性休克,可发生在做皮肤试验的当时,极少数可发生在连续用药过程中,迟发性过敏性休克),如不及时抢救,可危急生命,故用药前、中、后都要提高防护,以免发生意外。注意:应用前,必须问清有无过敏性疾病,用青霉素后有无皮疹、发热等变态反应出现,务必先做青霉素皮试。
7、氨曲南:偶有味觉异常、皮疹、轻度胃肠道反应,肌注局部疼痛,静注可出现静脉炎。
8、卡那霉素:本品对听神经和肾脏均有毒性,前者表现为耳鸣、听力减退、甚至永久性耳聋(因以前庭损害为主,故比较严重),为此对老年人、孕妇(可影响胎儿)必须高度警惕为孕;后者表现为蛋白尿、管型尿等。
9、采用磺胺甲恶唑患者有时引起胃肠道反应、结晶尿、血尿、皮疹、药热及白细胞减少。
10、头孢哌酮:肌注局部可有疼痛;偶见皮疹、药物热等变态反应;个别病人可出现全血细胞减少、一过性转氨酶升高、凝血酶原时间延长或出血等。
发明内容
为克服上述缺点,本发明的目的是发明一种治疗灼热型腋下急性化脓性淋巴结炎的中药制备方法。灼热型腋下急性化脓性淋巴结炎,属于祖国医学“腋痛”“夹肢痛”“夹痛”的范畴。腋下暴肿、灼热、疼痛而皮色不变,发热恶寒,上肢举动不利,二周成脓,易敛。《医宗金鉴·外科心法要诀·腋痈》云:“腋痈暴肿生腋间,肿硬火欣赤痛热寒,肝脾血热兼忿怒,初宜清解溃补痊。”
病因病机:素体蕴热,再加皮肤破损,毒邪乘机而入,“热之极为火”,而发本病。
临床表现:腋下灼热明显,口干、口渴、身热。1、初期:初起腋下多暴肿,皮色不变,灼热疼痛,同时上肢活动不利,伴有恶寒发热,纳呆,苔薄,脉滑数等症状。2、成脓:若疼痛日增,寒热不退,势在酿脓,消散的很少。经10~14天肿块中间变软,皮色转红,按之波动明显时,此为内脓已成。
它的技术方案为:取十大功劳叶6重量份、八仙草5重量份、三白草6重量份、大青叶8重量份、大金钱草6重量份、马尾连5重量份、马桑叶6重量份、马鞭草9重量份、天荞麦根6重量份、无花果6重量份、木槿皮5重量份、五色梅6重量份、牛西西5重量份、毛冬青6重量份、凤眼草6重量份、石蒜2重量份、田螺6重量份、白薇6重量份、白头翁5重量份、白花蛇舌草2重量份、山白菊6重量份、山海螺6重量份、千里光6重量份、千金藤6重量份、小飞扬草6重量份、半枝莲5重量份、地丁6重量份、朱砂根6重量份、连翘3重量份、岗梅根6重量份、忍冬藤2重量份、鸡蛋花6重量份、苦地胆5重量份、虎耳草6重量份、败酱草6重量份、罗锅底8重量份、金莲花6重量份和甘草9重量份,将以上38味中药放入1800毫升水中,浸泡30分钟,然后文火煎制30分钟,过滤去渣共煎药液390毫升,煎出的药液即为治疗灼热型腋下急性化脓性淋巴结炎的中药。
该发明的优点是:本方38味中药,在药店均能买到,制作简单,制成的中药液毒副作用小,疗程短,治愈率高。君臣佐使,恰到好处。应用中药的同时,避免了西药磺胺药、抗菌素引起的不良反应、过敏反应和毒性反应。十大功劳叶、八仙草、三白草、大青叶、大金钱草、马尾连、马桑叶、马鞭草、天荞麦根、无花果、木槿皮、五色梅、牛西西、毛冬青、凤眼草、石蒜、田螺、白薇、白头翁、白花蛇舌草,以上20味药具有清热解毒、利尿通淋、凉血止血,利水消肿、理气止痛、行瘀排脓之功效。在治疗灼热型腋下急性化脓性淋巴结炎的过程中,起主要治疗作用,故为君药。山白菊、山海螺、千里光、千金藤、小飞扬草、半枝莲、地丁、朱砂根、连翘、岗梅根、忍冬藤、鸡蛋花、苦地胆、虎耳草、败酱草、罗锅底,以上16味药具有凉血解毒,行血通络, 清热燥湿之功效。在治疗灼热型腋下急性化脓性淋巴结炎的过程中,能辅助主药发挥治疗作用,故为臣药。金莲花:苦,寒,无毒。入心、肝二经。清热解毒,清肝明目,辟秽解毒。能率诸药直达病灶,故为佐药。甘草:甘,平。入十二经。补脾润肺,益气复脉,缓急止痛,清热解毒,调和药性。既能纠诸药之偏性,又能缓解诸药之毒性,故为使药。十大功劳叶、八仙草、三白草、大青叶、大金钱草、马尾连、马桑叶、马鞭草、天荞麦根、无花果、木槿皮、五色梅、牛西西、毛冬青、凤眼草、石蒜、田螺、白薇、白头翁、白花蛇舌草、山白菊、山海螺、千里光、千金藤、小飞扬草、半枝莲、地丁、朱砂根、连翘、岗梅根、忍冬藤、鸡蛋花、苦地胆、虎耳草、败酱草、罗锅底、金莲花、甘草,这38味药配伍应用,共同起到清热解毒、利尿通淋、凉血止血,利水消肿、理气止痛、行瘀排脓、凉血解毒,行血通络, 清热燥湿之功效。君臣佐使,配伍得当,是治疗灼热型腋下急性化脓性淋巴结炎的最佳配方。十大功劳叶:苦,寒。入肝、胃、大肠三经。养阴清热,润肺止咳,清热解毒。八仙草:辛、苦,寒。入心、肺二经。清热利湿,活血散瘀,解毒消肿。三白草:甘、辛,寒,有小毒。入肺、脾、胃、大肠四经。清热利湿,利水消肿,解毒疗疮,消积化痞。大青叶:苦,寒。入心、胃二经。清热解毒,凉血消斑。大金钱草:甘、咸,微寒。入肝、胆、肾、膀胱四经。清热利湿,和胃降逆,解毒消肿,祛瘀消肿。马尾连:苦,寒。入心、肝、胆、大肠四经。清热燥湿,清热解毒,凉肝明目,利湿退黄。马桑叶:辛、苦,寒,有毒。入心、肺二经。清热解毒,祛风除湿。马鞭草:苦、辛,寒。入肝、脾二经。清热解毒,活血散瘀,利水消肿,截疟。天荞麦根:酸、苦,寒。入心、肺、脾、肝四经。清热解毒,清肺化痰,活血止痛,健脾消食。无花果:甘、平、酸,寒。入肺、胃、大肠三经。健胃厚肠,清热消肿,通乳。木槿皮:甘、苦,凉。入大肠、肝、脾三经。清热利湿,杀虫止痒,清热解毒。五色梅:苦,寒。入大肠经。解毒消肿,祛风止痒,止血。牛西西:苦、酸,寒。入心、肺、大、小肠四经。清热解毒,活血止血,泻火通便。毛冬青:微苦、甘,平。入肺、肝、大肠三经。清热解毒,活血通络,利水渗湿。凤眼草:苦、涩,寒。入大肠、肝、胃三经。清热燥湿,止血、止带。石蒜:辛、甘,温;有毒。入肺、胃二经。解毒消肿,祛痰平喘,利尿去水,催吐救急。田螺:甘、咸,寒。入肝、脾、胃、膀胱、大肠五经。清热利水,解毒消肿,生津止渴,凉血止血,醒酒。白薇:苦、咸,寒。入肺、胃、肾三经。清热凉血,利尿通淋,解毒疗疮,熄风止惊。白头翁:苦,寒。入大肠、肝、胃三经。清热解毒,凉血散瘀,截疟,清肝明目。白花蛇舌草:苦、甘,寒。入心、肝、脾三经。清热解毒,清热利湿,清热散瘀,治疗小儿疳积。山白菊:苦、辛,凉。入肺、肝二经。清热解毒,疏风解表,凉血止血。山海螺:甘、辛,平。入肺、大肠、肝二经。排脓生肌,解毒消肿,祛痰散结,催发乳汁。千里光:苦,寒。入肝、肾二经。清热解毒,清肝明目,祛风燥湿。千金藤:苦,寒。入肺、脾、大肠三经。清热解毒,利尿消肿,祛风活络。小飞扬草:酸、涩、苦,凉。入脾、胃、大肠三经。清热利湿,解毒消肿。半枝莲:辛、微苦,平。入心、肺、肝、肾四经。清热解毒,止血,散瘀止痛,行气利水。地丁:苦、辛,寒,无毒。入心、肝二经。清热解毒,清热利湿。朱砂根:辛、苦,寒。入肺、脾、胃三经。清热解毒,散瘀止痛。连翘:苦,凉。入心、肝、胆三经。清热解毒,消肿散结,清热利尿,治疗白虫病,经闭,疹子。岗梅根:苦、甘,寒。入肺、肝、大肠三经。清热解毒,跌打损伤,津伤口渴。忍冬藤:辛、甘,寒。入心、肺二经。清热解毒,舒筋活络,补虚疗风,散瘀止痛。鸡蛋花:甘,凉,无毒。入肺、大肠二经。清热解暑,清肠止痢,止咳化痰。苦地胆:苦、辛,寒。入肺、肝、脾三经。清热燥湿,凉血,清热解毒。虎耳草:微苦、辛、寒,有小毒。入肺、脾、大肠三经。祛风清热,解毒消肿,凉血止血。败酱草:辛、苦,微寒。入胃、大肠、肝三经。清热解毒,消痈化脓,祛瘀止痛,凉血止血,杀虫止痒。罗锅底:苦,寒,有毒。入胃、大肠二经。清热解毒,祛风利湿,凉血止血,消肿止痛。金莲花:苦,寒,无毒。入心、肝二经。清热解毒,清肝明目,辟秽解毒。甘草:甘,平。入十二经。补脾润肺,益气复脉,缓急止痛,清热解毒,调和药性。
具体实施方式:
取十大功劳叶6g、八仙草5g、三白草6g、大青叶8g、大金钱草6g、马尾连5g、马桑叶6g、马鞭草9g、天荞麦根6g、无花果6g、木槿皮5g、五色梅6g、牛西西5g、毛冬青6g、凤眼草6g、石蒜2g、田螺6g、白薇6g、白头翁5g、白花蛇舌草2g、山白菊6g、山海螺6g、千里光6g、千金藤6g、小飞扬草6g、半枝莲5g、地丁6g、朱砂根6g、连翘3g、岗梅根6g、忍冬藤2g、鸡蛋花6g、苦地胆5g、虎耳草6g、败酱草6g、罗锅底8g、金莲花6g和甘草9g,将以上38味药一起放入1800毫升水中,浸泡30分钟,然后文火煎制30分钟,过滤去渣,煎出的药液即为治疗灼热型腋下急性化脓性淋巴结炎的中药。共煎药液390毫升,当灼热型腋下急性化脓性淋巴结炎的病人需要治疗时,使药液温度为35℃,每次130毫升,口服,每日三次, 二日为一疗程,若症状仍存,再服第二疗程,以至痊愈。
387例灼热型腋下急性化脓性淋巴结炎患者中,男性256例,占66.1%;女性131例,占33.9%。男性多于女性。
表一、387例灼热型腋下急性化脓性淋巴结炎患者的年龄范围
| 年龄(岁) | 23~30 | 31~40 | 41~50 | 51~66 |
| 例数 | 16 | 227 | 131 | 13 |
| 百分比 | 4.1% | 58.7% | 33.9% | 3.3% |
表二、387例灼热型腋下急性化脓性淋巴结炎患者疗效表
| 疗效 | 治愈 | 好转 | 无效 |
| 例数 | 385 | 2 | 无 |
| 百分比 | 99.48% | 0.52% | 无 |
表三、387例灼热型腋下急性化脓性淋巴结炎患者疗程表
| 治疗天数 | 3~5 | 6~9 | 10~14 | 15~25 |
| 例数 | 11 | 232 | 135 | 9 |
| 百分比 | 2.8% | 60% | 34.9% | 2.3% |
表四、387例灼热型腋下急性化脓性淋巴结炎患者治疗前后情况表
Claims (1)
1.一种治疗灼热型腋下急性化脓性淋巴结炎的中药制备方法,其特征是:取十大功劳叶6克、八仙草5克、三白草6克、大青叶8克、大金钱草6克、马尾连5克、马桑叶6克、马鞭草9克、天荞麦根6克、无花果6克、木槿皮5克、五色梅6克、牛西西5克、毛冬青6克、凤眼草6克、石蒜2克、田螺6克、白薇6克、白头翁5克、白花蛇舌草2克、山白菊6克、山海螺6克、千里光6克、千金藤6克、小飞扬草6克、半枝莲5克、地丁6克、朱砂根6克、连翘3克、岗梅根6克、忍冬藤2克、鸡蛋花6克、苦地胆5克、虎耳草6克、败酱草6克、罗锅底8克、金莲花6克和甘草9克,将以上38味中药放入1800毫升水中,浸泡30分钟,然后文火煎制30分钟,过滤去渣共煎药液390毫升,煎出的药液即为治疗灼热型腋下急性化脓性淋巴结炎的中药。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013103675023A CN103432310A (zh) | 2013-08-22 | 2013-08-22 | 一种治疗灼热型腋下急性化脓性淋巴结炎的中药制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013103675023A CN103432310A (zh) | 2013-08-22 | 2013-08-22 | 一种治疗灼热型腋下急性化脓性淋巴结炎的中药制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103432310A true CN103432310A (zh) | 2013-12-11 |
Family
ID=49686095
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013103675023A Pending CN103432310A (zh) | 2013-08-22 | 2013-08-22 | 一种治疗灼热型腋下急性化脓性淋巴结炎的中药制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103432310A (zh) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103251749A (zh) * | 2013-05-25 | 2013-08-21 | 靳先玲 | 一种治疗过食肥肉型贲门炎的中药制备方法 |
| CN103251810A (zh) * | 2013-05-25 | 2013-08-21 | 杜守勤 | 一种治疗热毒型贲门炎的中药制备方法 |
-
2013
- 2013-08-22 CN CN2013103675023A patent/CN103432310A/zh active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103251749A (zh) * | 2013-05-25 | 2013-08-21 | 靳先玲 | 一种治疗过食肥肉型贲门炎的中药制备方法 |
| CN103251810A (zh) * | 2013-05-25 | 2013-08-21 | 杜守勤 | 一种治疗热毒型贲门炎的中药制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 冉先德: "《中华药海 上》", 31 August 1993, 哈尔滨出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102743630B (zh) | 一种治疗嗜食大蒜型蜂窝组织炎的中药洗剂制备方法 | |
| CN102743565B (zh) | 一种治疗焮红型蜂窝组织炎的中药洗剂制备方法 | |
| CN102743633A (zh) | 一种治疗腐肉型蜂窝组织炎的中药洗剂制备方法 | |
| CN103463523B (zh) | 一种治疗热毒炽盛型腋下急性化脓性淋巴结炎中药 | |
| CN103463434A (zh) | 一种治疗发热型腋下急性化脓性淋巴结炎的中药制备方法 | |
| CN103463370B (zh) | 一种治疗嗜食牛肚型腋下急性化脓性淋巴结炎的中药 | |
| CN103463337B (zh) | 一种治疗经络阻滞型腋下急性化脓性淋巴结炎的中药 | |
| CN103446359A (zh) | 一种治疗过食肥肉型前庭大腺炎的中药洗剂制备方法 | |
| CN103463433A (zh) | 一种治疗口渴型腋下急性化脓性淋巴结炎的中药制备方法 | |
| CN103432310A (zh) | 一种治疗灼热型腋下急性化脓性淋巴结炎的中药制备方法 | |
| CN103432405B (zh) | 一种治疗嗜食肥肉型腋下急性化脓性淋巴结炎的中药 | |
| CN103432454A (zh) | 一种治疗酗酒型腋下急性化脓性淋巴结炎的中药制备方法 | |
| CN103432406A (zh) | 一种治疗肿块型腋下急性化脓性淋巴结炎的中药制备方法 | |
| CN103432408B (zh) | 一种治疗痰浊壅塞型腋下急性化脓性淋巴结炎的中药 | |
| CN103463336B (zh) | 一种治疗过食川椒型腋下急性化脓性淋巴结炎的中药 | |
| CN103432451B (zh) | 一种治疗过食猪大肠型腋下急性化脓性淋巴结炎的中药 | |
| CN103432404A (zh) | 一种治疗嗜食辣椒型腋下急性化脓性淋巴结炎的中药 | |
| CN103446480B (zh) | 一种治疗过食熏鸡型腋下急性化脓性淋巴结炎的中药 | |
| CN103432483A (zh) | 一种治疗瘀血型腋下急性化脓性淋巴结炎的中药制备方法 | |
| CN103432409B (zh) | 一种治疗嗜食烤肉型腋下急性化脓性淋巴结炎的中药 | |
| CN103432402A (zh) | 一种治疗疼痛型腋下急性化脓性淋巴结炎的中药制备方法 | |
| CN103432407B (zh) | 一种治疗过食猪肝型腋下急性化脓性淋巴结炎的中药 | |
| CN103432403A (zh) | 一种治疗嗜食大蒜型腋下急性化脓性淋巴结炎的中药 | |
| CN103463323A (zh) | 一种治疗腋下暴肿型腋下急性化脓性淋巴结炎的中药 | |
| CN103463319A (zh) | 一种治疗嗜食鲜姜型前庭大腺炎的中药洗剂制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C12 | Rejection of a patent application after its publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20131211 |
